Literature DB >> 18755517

Yeast chemical genomics and drug discovery: an update.

Shawn Hoon1, Robert P St Onge, Guri Giaever, Corey Nislow.   

Abstract

The Saccharomyces cerevisiae sequencing project (the first eukaryotic genome decoded) was completed in 1995 and, subsequently, the first version of the yeast knockout collection was made available in 2002. Since then, many diverse studies have applied these resources to understand drug mechanism of action and to identify novel drug targets and target pathways. In this update of an earlier review, we present a snapshot of the current state of chemical genomic approaches in yeast, propose a set of integrated chemical genomic assays to move the field forward and consider its near-term future.

Entities:  

Mesh:

Year:  2008        PMID: 18755517     DOI: 10.1016/j.tips.2008.07.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  40 in total

Review 1.  Bugs, drugs and chemical genomics.

Authors:  Terry Roemer; Julian Davies; Guri Giaever; Corey Nislow
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

2.  Identification of a small molecule yeast TORC1 inhibitor with a multiplex screen based on flow cytometry.

Authors:  Jun Chen; Susan M Young; Chris Allen; Andrew Seeber; Marie-Pierre Péli-Gulli; Nicolas Panchaud; Anna Waller; Oleg Ursu; Tuanli Yao; Jennifer E Golden; J Jacob Strouse; Mark B Carter; Huining Kang; Cristian G Bologa; Terry D Foutz; Bruce S Edwards; Blake R Peterson; Jeffrey Aubé; Margaret Werner-Washburne; Robbie J Loewith; Claudio De Virgilio; Larry A Sklar
Journal:  ACS Chem Biol       Date:  2012-02-01       Impact factor: 5.100

3.  A systems biology approach to dissection of the effects of small bicyclic peptidomimetics on a panel of saccharomyces cerevisiae mutants.

Authors:  Irene Stefanini; Andrea Trabocchi; Emmanuela Marchi; Antonio Guarna; Duccio Cavalieri
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

4.  Quantitative- and phospho-proteomic analysis of the yeast response to the tyrosine kinase inhibitor imatinib to pharmacoproteomics-guided drug line extension.

Authors:  Sandra C Dos Santos; Nuno P Mira; Ana S Moreira; Isabel Sá-Correia
Journal:  OMICS       Date:  2012-07-09

5.  Involvement of the pleiotropic drug resistance response, protein kinase C signaling, and altered zinc homeostasis in resistance of Saccharomyces cerevisiae to diclofenac.

Authors:  Jolanda S van Leeuwen; Nico P E Vermeulen; J Chris Vos
Journal:  Appl Environ Microbiol       Date:  2011-07-01       Impact factor: 4.792

6.  Systems-level antimicrobial drug and drug synergy discovery.

Authors:  Terry Roemer; Charles Boone
Journal:  Nat Chem Biol       Date:  2013-04       Impact factor: 15.040

7.  High-content, image-based screening for drug targets in yeast.

Authors:  Shinsuke Ohnuki; Satomi Oka; Satoru Nogami; Yoshikazu Ohya
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

8.  Gene annotation and drug target discovery in Candida albicans with a tagged transposon mutant collection.

Authors:  Julia Oh; Eula Fung; Ulrich Schlecht; Ronald W Davis; Guri Giaever; Robert P St Onge; Adam Deutschbauer; Corey Nislow
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Genome-wide screen in Saccharomyces cerevisiae identifies vacuolar protein sorting, autophagy, biosynthetic, and tRNA methylation genes involved in life span regulation.

Authors:  Paola Fabrizio; Shawn Hoon; Mehrnaz Shamalnasab; Abdulaye Galbani; Min Wei; Guri Giaever; Corey Nislow; Valter D Longo
Journal:  PLoS Genet       Date:  2010-07-15       Impact factor: 5.917

10.  Global fitness profiling of fission yeast deletion strains by barcode sequencing.

Authors:  Tian Xu Han; Xing-Ya Xu; Mei-Jun Zhang; Xu Peng; Li-Lin Du
Journal:  Genome Biol       Date:  2010-06-10       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.